Diabetes
Page 3 of 9
By Stephanie WatsonJuly 29, 2024
By Beth GreenfieldJuly 12, 2024
By Robert Langreth and BloombergJuly 3, 2024
HealthFake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
By Amanda LoudinJune 27, 2024
HealthEU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
By Naomi Kresge and BloombergJune 26, 2024
RetailOzempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
By Jordyn BradleyJune 15, 2024
HealthUsher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to Capitol Hill
By Rachel VentrescaJune 5, 2024
HealthCould drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential longevity pills
By Jessica FirgerMay 25, 2024
HealthGLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
By Jonel Aleccia and The Associated PressApril 12, 2024
HealthStudy shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
By Naomi Kresge and BloombergApril 6, 2024
By Liz SeegertApril 4, 2024
Most Popular
